Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1617-1622
Published online before print June 2, 2005, doi: 10.1161/01.ATV.0000172626.00296.ba
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/8/1617    most recent
01.ATV.0000172626.00296.bav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunnett, C.A.
Right arrow Articles by Heistad, D.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunnett, C.A.
Right arrow Articles by Heistad, D.D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Carotid Artery Disease
*Vasculitis
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1617.)
© 2005 American Heart Association, Inc.


Vascular Biology

Mechanisms of Inducible Nitric Oxide Synthase–Mediated Vascular Dysfunction

C.A. Gunnett; D.D. Lund; A.K. McDowell; F.M. Faraci; D.D. Heistad

From the Departments of Internal Medicine (C.A.G., D.D.L., F.M.F., D.D.H.) and Pharmacology (A.K.M., F.M.F., D.D.H.), University of Iowa Carver College of Medicine and VA Medical Center, Iowa City, Iowa.

Correspondence to Donald D. Heistad, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242. E-mail donald-heistad{at}uiowa.edu

Objective— Inducible nitric oxide synthase (iNOS) is expressed in arteries during inflammation and may contribute to vascular dysfunction. Effects of gene transfer of iNOS to carotid arteries were examined in vitro in the absence of systemic inflammation to allow examination of mechanisms by which iNOS impairs contraction and relaxation.

Methods and Results— After gene transfer of iNOS with an adenovirus (AdiNOS), constrictor responses to phenylephrine (PE) and U46619 were impaired. After AdiNOS, inhibition of soluble guanylate cyclase (sGC) with 1H-[1,2,4]oxadiazolo-[4,3,2]quinoxalin-1-one (ODQ) reduced the EC50 for PE from 4.33±0.78 µmol/L to 1.15±0.43 µmol/L (mean±SEM). These results imply that iNOS impairs contraction by activation of the NO/cGMP pathway. Relaxation to acetylcholine (ACh) also was impaired after AdiNOS. Sepiapterin (300 µmol/L), the precursor for tetrahydrobiopterin (BH4), improved relaxation to Ach. Because BH4 is an essential cofactor for production of NO by both iNOS and endothelial nitric oxide synthase (eNOS), these results suggest that iNOS may reduce production of NO by eNOS by limiting availability of BH4. Next, we examined effects of expression of iNOS in endothelium and adventitia. Selective expression of iNOS in endothelium, but not adventitia, impaired contraction to phenylephrine and relaxation to acetylcholine.

Conclusions— We conclude that: (1) iNOS may impair contraction in part by activation of sGC; (2) iNOS impairs relaxation, at least in part, by limiting availability of BH4; and (3) expression of iNOS in endothelium may be a more important mediator of vascular dysfunction than expression of iNOS in adventitia.

Inducible nitric oxide synthase (iNOS) is expressed in arteries during inflammation and may impair vascular contraction of rabbit carotid artery by activation of soluble guanylate cyclase. iNOS also impairs vascular relaxation by limiting availability of BH4. Furthermore, expression of iNOS in endothelium impairs vascular function more than expression of iNOS in adventitia.


Key Words: acetylcholine • adenovirus • gene transfer • sepiapterin




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
H. Soliman, G. P. Craig, P. Nagareddy, V. G. Yuen, G. Lin, U. Kumar, J. H. McNeill, and K. M. MacLeod
Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats
Cardiovasc Res, July 15, 2008; 79(2): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. H. Lee, S. Xia, and L. Ragolia
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R144 - R154.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Machida, Y. Hamaya, S. Izumi, Y. Hamaya, K. Iizuka, Y. Igarashi, M. Minami, R. Levi, and M. Hirafuji
Sphingosine 1-Phosphate Inhibits Nitric Oxide Production Induced by Interleukin-1{beta} in Rat Vascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 200 - 209.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Zhang, T. Tazzeo, V. Chu, and L. J. Janssen
Membrane potassium currents in human radial artery and their regulation by nitric oxide donor
Cardiovasc Res, July 15, 2006; 71(2): 383 - 392.
[Abstract] [Full Text] [PDF]